DR. RAYMOND EDWARD HENSHAW II, M.D.

Plain English
This research studied a program that gave nursing students hands-on experience with arts-based activities to improve health and well-being. Out of 60 participants, 81.8% felt that working with artists enhanced their understanding of creative health practices, and 86.4% acknowledged its positive impact on well-being. This is important because incorporating creative health into nursing education can better prepare future nurses to support patients through social prescribing and arts engagement. Who this helps: This benefits nursing students and their future patients.

Plain English
This study looked at how well a new bone stabilization device, called the IlluminOss System, works for patients with fractures in the upper arm caused by cancer. After one year, patients experienced a big reduction in pain, going from an average score of 84 down to just 21, and their ability to use their arm improved significantly, with function scores increasing from 27 to 83. This matters because it shows that the IlluminOss System can effectively relieve pain and boost function for patients with these types of fractures. Who this helps: Patients with metastatic bone disease affecting the humerus.

Plain English
This study looked at how effective and safe denosumab is for treating giant cell tumors in the spine, especially for patients who can't have surgery. Out of 132 patients, the chances of their disease getting worse or coming back were low: 3% after one year and 7.4% after three and five years. This is important because it shows that denosumab could be a good alternative treatment for patients with this challenging condition. Who this helps: Patients with giant cell tumors in the spine.

Plain English
This study looked at a new device called the Photodynamic Bone Stabilization System (PBSS) used to treat fractures in the upper arm caused by cancer. Out of 29 implants, 8 failed, translating to a 27.5% failure rate, and 20% of patients needed additional surgery due to complications. This is important because while the PBSS could help monitor healing and reduce radiation interference, it seems less effective in certain situations, particularly for fractures in the lower part of the upper arm. Who this helps: This research helps doctors treating patients with cancer-related bone fractures.

Plain English
This research focused on a support network in Queensland aimed at improving emergency healthcare by helping doctors engage in research. Over two years, the network assisted 33 emergency departments, increasing the number of clinicians involved in research from 23 to 181, and the number of research presentations grew from 6 to 61. This work is important because it enhances the ability of healthcare professionals to provide evidence-based care, ultimately benefiting patient outcomes. Who this helps: This helps patients and their doctors by improving the quality of emergency healthcare services.

Plain English
This study looked at the effectiveness and safety of a drug called denosumab in patients with giant-cell tumor of bone (GCTB), a type of bone tumor. Out of 532 patients, 92% in one group were able to avoid surgery for at least six months after starting the treatment. The study found that while there were some serious side effects like osteonecrosis of the jaw and anemia, the overall benefits of reducing tumor growth seem to outweigh the risks. Who this helps: This benefits patients with giant-cell tumor of bone and their doctors.

Plain English
This study looked at how experts in regional Queensland use drug trend data to address issues related to alcohol and substance abuse. Researchers interviewed 21 key professionals and found that those in law and criminal justice felt they had access to good data, while many in the health sector felt there was a lack of current information, especially in rural areas. This lack of data makes it harder to understand and respond to changing substance use patterns in these regions. Who this helps: This helps doctors and healthcare workers in regional areas better understand and tackle substance abuse issues.

Plain English
This study looked at how well a treatment called denosumab works for patients with giant cell tumor of bone (GCTB) by measuring changes in tumor size using different imaging techniques. The findings showed that 71.6% of patients had a positive response to the treatment, with 96.2% responding well according to PET scan criteria. This is important because it shows that denosumab is effective at controlling tumors, which can help improve patient outcomes. Who this helps: This benefits patients with giant cell tumor of bone and their doctors.

Plain English
This study examined how people in regional Queensland who use performance and image enhancing drugs (PIEDs) access health services. Researchers spoke with 21 users and found that while they could access services like needle exchange programs and pharmacies for clean injecting equipment, many felt stigma around their drug use affected their treatment by healthcare providers. Participants often avoided talking about their PIED use with their doctors due to fear of being judged and losing care, but they reported no significant barriers based on living in a rural area. Who this helps: This benefits patients who use PIEDs and healthcare providers looking to improve their care.

Plain English
The study examined a 55-year-old woman who experienced a severe allergic reaction (anaphylaxis) to vancomycin, an antibiotic she had used multiple times before without problems. After her reaction, which included a serious condition called disseminated intravascular coagulation, she was treated with fluids, blood components, steroids, and epinephrine, and ultimately recovered well enough to undergo surgery again. This case is important because it highlights that even patients with previous vancomycin exposure can have serious allergic reactions to it. Who this helps: This information is beneficial for doctors and healthcare providers when prescribing antibiotics, especially for patients with prior exposure.

Plain English
This study looked at how safe and effective a drug called denosumab is for adults and older teens with giant cell tumors of the bone, a rare and aggressive type of tumor. Out of 282 patients, 96% of those with GCTB that couldn't be surgically removed showed no disease progression after about a year, and 74% of those who could have surgery avoided it altogether or had less invasive procedures. This research matters because it offers a new treatment option for a condition that currently has no standard medical treatment. Who this helps: This helps patients with giant cell tumors of the bone.

Plain English
This study looked at how obesity affects the quality of embryos and pregnancy outcomes for women under 38 years old undergoing in vitro fertilization (IVF). The researchers found that morbidly obese women (with a BMI of 40 or higher) had lower pregnancy rates (30.5%) compared to normal weight women (41.7%) and experienced more preterm deliveries. Although embryo development was not impacted, higher BMI was linked to delivering larger babies and more cases of premature births. Who this helps: This information is valuable for women seeking IVF and their healthcare providers.

Plain English
This study examined a rare type of tumor called benign mesenchymoma in a 13-year-old boy, who is one of only two reported cases in young patients. The researchers looked closely at the boy’s symptoms, scans, and tissue samples and noted that this type of tumor is not cancerous and is very uncommon. Understanding these rare tumors is important because it helps doctors accurately diagnose and treat similar cases in children. Who this helps: This benefits doctors and pediatric patients with rare tumors.

Plain English
This study looked at how injuries to the anterior cruciate ligament (ACL) in rabbits affect certain genes related to healing. When the ACL was partially cut, there was a significant increase—28 to 29 times—of specific proteins (MMP-13 and alpha-SMA) that play roles in tissue breakdown and repair within the first week. By six weeks after surgery, collagen levels also rose significantly, indicating that the healing process changes over time. Who this helps: This research benefits patients recovering from ACL injuries, as it may lead to better treatment options.

Plain English
This study looked at how well denosumab, a targeted therapy, works for treating patients with giant-cell tumors of the bone, which can cause significant pain and health problems. Out of 35 patients who were monitored, 30 (or 86%) responded positively to the treatment by either showing a significant reduction in tumor cells or no progression of the disease within 25 weeks. Although some patients experienced side effects, the treatment showed promising results, indicating that denosumab might be a valuable option for these patients. Who this helps: Patients with giant-cell tumors of the bone.

Plain English
This study looked at the complications and outcomes for patients who received artificial implants after having bone tumors removed. Researchers followed 232 patients for an average of 10 years and found that 29% of implants failed, mostly due to mechanical issues and infections. Importantly, the study revealed that modular implants, which can be adjusted and replaced, resulted in fewer complications and infections compared to custom implants, leading to better overall outcomes. Who this helps: This is beneficial for patients undergoing surgery for bone tumors and their doctors, as it provides insights into improving surgical outcomes and implant choices.

Plain English
This study looked at how stretching affects ligament cells, specifically those from the anterior cruciate ligament (ACL) and the medial collateral ligament (MCL). Researchers found that MCL cells grew faster on a fibronectin surface but were less likely to grow under stretching compared to ACL cells. Notably, under 5% stretching, the expression of specific proteins (integrins) that help cells attach and communicate increased, especially in MCL cells, with the beta3 integrin showing a significant 90% rise when grown on laminin. Who this helps: This research benefits doctors and researchers focused on ligament injuries and rehabilitation.

Plain English
This study looked at two treatments for heavy menstrual bleeding: microwave endometrial ablation (MEA) and the Mirena intrauterine device. It found that both treatments significantly reduced bleeding and pain, and women were very satisfied with both options—over 90% reported a positive experience. Importantly, neither treatment was shown to be better than the other in terms of effectiveness or side effects. Who this helps: This information benefits women experiencing heavy menstrual bleeding and their healthcare providers in choosing effective treatment options.

Plain English
This study looked at how much women value different abortion methods—medical abortion versus surgical vacuum aspiration. Out of 50 women studied, 34 (64%) preferred the medical abortion, with some women willing to pay more for that option, indicating a strong preference for it. Understanding these preferences helps policymakers and healthcare providers offer better options that align with women's feelings about their healthcare choices. Who this helps: This benefits patients seeking abortion services.

Plain English
This study looked at the costs of treating miscarriage using surgical versus medical methods in Scotland. It found that the average cost of surgical treatment was £397, while medical treatment averaged £347, suggesting that medical management could save money overall. The potential savings from using medical treatment could vary, ranging from a £71 saving to a potential cost increase of £47 per patient, depending on certain factors. Who this helps: This information benefits healthcare providers and patients experiencing miscarriage by highlighting more affordable treatment options.

Plain English
This study looked at how a protein called basic fibroblast growth factor (bFGF) can protect brain cells from damage caused by toxic chemicals in both young and adult rats. The researchers found that giving bFGF significantly reduced brain cell death—in adult rats, a dose of 100 micrograms per kilogram led to strong protection against damage, while in neonatal rats, using either a single or three doses of 300 or 100 micrograms per kilogram provided about 50% protection from toxicity. This is important because it suggests that bFGF could be a potential treatment for conditions like stroke where brain injury occurs. Who this helps: This helps patients who are at risk of stroke or other conditions that may harm the brain.

Plain English
Researchers studied the effects of a harmful compound called 3-nitropropionic acid (3-NP) on mice that have a special gene to help detoxify damaging oxygen radicals. They found that these special mice, called Tg-SOD mice, experienced much less brain damage compared to regular mice when exposed to 3-NP. Specifically, the damages measured in the brains of Tg-SOD mice were significantly lower, showing that their special gene helps protect against the harmful effects of 3-NP. This research is important because it highlights the role of oxygen-related damage in certain brain injuries and may guide future treatments for similar conditions. Who this helps: This helps patients with neurodegenerative diseases and their doctors.

Plain English
The researchers studied how malonate, a chemical compound, causes damage in a specific part of the brain called the striatum, especially focusing on different ages in rats. They found that older rats had more brain damage from malonate. However, treatments with certain drugs significantly protected younger rats from this damage. This research is important because it suggests that issues with energy use in the brain might be linked to diseases that cause brain cell death. Who this helps: This helps patients with neurodegenerative diseases and their doctors.

Plain English
In this study, researchers examined two related proteins, Rev-erb alpha and Rev-erb beta, along with ROR alpha 1, to understand how they interact and affect gene activity. They found that while ROR alpha 1 boosts gene expression, Rev-erb proteins work against it, effectively canceling out ROR alpha 1's effects when both are present. This understanding is important because it reveals how these proteins work together to regulate vital processes in the body, which can help inform future treatments for conditions influenced by these pathways. Who this helps: This benefits researchers and doctors looking for new ways to treat diseases related to gene regulation.

Plain English
This study compared the psychological effects of two abortion methods: medical abortion using pills (mifepristone and gemeprost) and surgical vacuum aspiration. Researchers followed 363 women and found that both methods resulted in similar levels of anxiety, depression, and self-esteem after the procedure, indicating that neither method is more psychologically harmful than the other. Importantly, women who had mood issues before the abortion, smoked, or experienced medical complications afterwards were found to be more at risk for mood disorders post-abortion. Who this helps: This research benefits women considering their options for abortion by showing that both methods are psychologically safe.

Plain English
Researchers studied the effects of a substance called malonate, which can disrupt energy production in brain cells, by injecting it into the brains of young and older animals. They found that both the 4- and 12-month-old animals had more severe brain damage compared to the 1-month-old animals, and this damage could be reduced by a specific drug called MK-801. These findings suggest that mild energy problems might contribute to Huntington's disease, a serious brain disorder. Who this helps: This research helps patients with Huntington's disease and their doctors by improving understanding of the disease's mechanisms.

Plain English
Researchers studied the effects of indoramin on men with urinary problems caused by enlarged prostates. They found that taking 20 mg of indoramin twice a day improved urine flow by 50% compared to a placebo. Most patients reported feeling better while taking indoramin, and the treatment was generally well tolerated. Who this helps: This helps men suffering from symptoms of benign prostatic hypertrophy.